24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Therapix
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
09:09
CTech’s Book Review: What strategy really is and why so many organizations get it wrong
08:20
British Ambassador to Israel, Simon Walters: “If you build in Britain, we will back you”
08:03
The end-of-year tech layoffs are not a crisis - they mark a paradigm shift
07:29
MSC denies interest in acquiring ZIM
More stories
Buzz
Most popular
Daily
Weekly
1
Huang declares Israel Nvidia’s “second home” with record-breaking campus investment
2
Vega raises $120 million Series B as two-year-old cyber startup hits $700 million valuation
3
Cyera raises $400 million at $9 billion valuation in Blackstone-led round
4
Dell acquires AI data-infrastructure startup Dataloop in $120 million all-cash deal
5
“The acquisition of Armis marks a clear entry by ServiceNow into cybersecurity”
More news
Therapix
4 stories about Therapix
Cannabis Companies Therapix and Destiny to Merge
28.07.19
|
Adi Pick
The merged company will focus on Therapix's technology and assets pertaining to clinical-stage pharmaceutical applications of cannabis, and will include Destiny's genomics-based cannabis breeding techniques and development capabilities
Cannabis Company Therapix Biosciences to Raise $2.25 Million in Direct Offering
28.03.19
|
Lilach Baumer
In December, Israel-based Therapix scrapped a deal to be acquired by Canadian FSD Pharma for $48 million worth of FSD stock
FSD Pharma’s Acquisition of Therapix Hits a Snag
12.12.18
|
Tzally Greenberg
In October, FSD agreed to buy Therapix for $48 million in stock, but a Tuesday filing by Therapix revealed that the companies have returned to the negotiating table
FSD Pharma Co-Chairman on Where the Cannabis Industry Is Headed
28.11.18
|
Tzally Greenberg
On a visit to Israel, the co-chairman of the company said he believes cannabis research is going to come from Israel and Australia. He expects China to become a significant player in the cannabis market